Rebecca R. Begley, Ph.D.
Affiliations: | 2004 | Stanford University, Palo Alto, CA |
Area:
chemical and systems biologyGoogle:
"Rebecca Begley"Mean distance: 21373.2
Parents
Sign in to add mentor| Daria Mochly-rosen | grad student | 2004 | Stanford | |
| (Therapeutic in vivo applications for PKC-modulating intracellularly-acting peptides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Frumkin LR, Lucas M, Scribner CL, et al. (2022) Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19. Frontiers in Immunology. 13: 899617 |
| Malhotra A, Begley R, Kang BP, et al. (2005) PKC-{epsilon}-dependent survival signals in diabetic hearts. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1343-50 |
| Inagaki K, Begley R, Ikeno F, et al. (2005) Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation. 111: 44-50 |
| Begley R, Liron T, Baryza J, et al. (2004) Biodistribution of intracellularly acting peptides conjugated reversibly to Tat. Biochemical and Biophysical Research Communications. 318: 949-54 |
| Begley RR, Inagaki K, Powers J, et al. (2003) Postnatal cardiac hypertrophy is modulated by εPKC activity Journal of Cardiac Failure. 9: S70 |